Cargando…
Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
We present the results from the pediatric arm of the Polish Registry of Pulmonary Hypertension. We prospectively enrolled all pulmonary arterial hypertension (PAH) patients, between the ages of 3 months and 18 years, who had been under the care of each PAH center in Poland between 1 March 2018 and 3...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356296/ https://www.ncbi.nlm.nih.gov/pubmed/32503164 http://dx.doi.org/10.3390/jcm9061717 |
_version_ | 1783558467921903616 |
---|---|
author | Kwiatkowska, Joanna Zuk, Malgorzata Migdal, Anna Kusa, Jacek Skiba, Elzbieta Zygielo, Karolina Przetocka, Kinga Werynski, Piotr Banaszak, Pawel Rzeznik-Bieniaszewska, Alina Surmacz, Rafal Bobkowski, Waldemar Wojcicka-Urbanska, Barbara Werner, Bozena Pluzanska, Joanna Ostrowska, Katarzyna Waldoch, Anna Kopec, Grzegorz |
author_facet | Kwiatkowska, Joanna Zuk, Malgorzata Migdal, Anna Kusa, Jacek Skiba, Elzbieta Zygielo, Karolina Przetocka, Kinga Werynski, Piotr Banaszak, Pawel Rzeznik-Bieniaszewska, Alina Surmacz, Rafal Bobkowski, Waldemar Wojcicka-Urbanska, Barbara Werner, Bozena Pluzanska, Joanna Ostrowska, Katarzyna Waldoch, Anna Kopec, Grzegorz |
author_sort | Kwiatkowska, Joanna |
collection | PubMed |
description | We present the results from the pediatric arm of the Polish Registry of Pulmonary Hypertension. We prospectively enrolled all pulmonary arterial hypertension (PAH) patients, between the ages of 3 months and 18 years, who had been under the care of each PAH center in Poland between 1 March 2018 and 30 September 2018. The mean prevalence of PAH was 11.6 per million, and the estimated incidence rate was 2.4 per million/year, but it was geographically heterogeneous. Among 80 enrolled children (females, n = 40; 50%), 54 (67.5%) had PAH associated with congenital heart disease (CHD-PAH), 25 (31.25%) had idiopathic PAH (IPAH), and 1 (1.25%) had portopulmonary PAH. At the time of enrolment, 31% of the patients had significant impairment of physical capacity (WHO-FC III). The most frequent comorbidities included shortage of growth (n = 20; 25%), mental retardation (n = 32; 40%), hypothyroidism (n = 19; 23.8%) and Down syndrome (n = 24; 30%). The majority of children were treated with PAH-specific medications, but only half of them with double combination therapy, which improved after changing the reimbursement policy. The underrepresentation of PAH classes other than IPAH and CHD-PAH, and the geographically heterogeneous distribution of PAH prevalence, indicate the need for building awareness of PAH among pediatricians, while a frequent coexistence of PAH with other comorbidities calls for a multidisciplinary approach to the management of PAH children. |
format | Online Article Text |
id | pubmed-7356296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73562962020-07-31 Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) Kwiatkowska, Joanna Zuk, Malgorzata Migdal, Anna Kusa, Jacek Skiba, Elzbieta Zygielo, Karolina Przetocka, Kinga Werynski, Piotr Banaszak, Pawel Rzeznik-Bieniaszewska, Alina Surmacz, Rafal Bobkowski, Waldemar Wojcicka-Urbanska, Barbara Werner, Bozena Pluzanska, Joanna Ostrowska, Katarzyna Waldoch, Anna Kopec, Grzegorz J Clin Med Article We present the results from the pediatric arm of the Polish Registry of Pulmonary Hypertension. We prospectively enrolled all pulmonary arterial hypertension (PAH) patients, between the ages of 3 months and 18 years, who had been under the care of each PAH center in Poland between 1 March 2018 and 30 September 2018. The mean prevalence of PAH was 11.6 per million, and the estimated incidence rate was 2.4 per million/year, but it was geographically heterogeneous. Among 80 enrolled children (females, n = 40; 50%), 54 (67.5%) had PAH associated with congenital heart disease (CHD-PAH), 25 (31.25%) had idiopathic PAH (IPAH), and 1 (1.25%) had portopulmonary PAH. At the time of enrolment, 31% of the patients had significant impairment of physical capacity (WHO-FC III). The most frequent comorbidities included shortage of growth (n = 20; 25%), mental retardation (n = 32; 40%), hypothyroidism (n = 19; 23.8%) and Down syndrome (n = 24; 30%). The majority of children were treated with PAH-specific medications, but only half of them with double combination therapy, which improved after changing the reimbursement policy. The underrepresentation of PAH classes other than IPAH and CHD-PAH, and the geographically heterogeneous distribution of PAH prevalence, indicate the need for building awareness of PAH among pediatricians, while a frequent coexistence of PAH with other comorbidities calls for a multidisciplinary approach to the management of PAH children. MDPI 2020-06-03 /pmc/articles/PMC7356296/ /pubmed/32503164 http://dx.doi.org/10.3390/jcm9061717 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kwiatkowska, Joanna Zuk, Malgorzata Migdal, Anna Kusa, Jacek Skiba, Elzbieta Zygielo, Karolina Przetocka, Kinga Werynski, Piotr Banaszak, Pawel Rzeznik-Bieniaszewska, Alina Surmacz, Rafal Bobkowski, Waldemar Wojcicka-Urbanska, Barbara Werner, Bozena Pluzanska, Joanna Ostrowska, Katarzyna Waldoch, Anna Kopec, Grzegorz Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) |
title | Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) |
title_full | Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) |
title_fullStr | Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) |
title_full_unstemmed | Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) |
title_short | Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) |
title_sort | children and adolescents with pulmonary arterial hypertension: baseline and follow-up data from the polish registry of pulmonary hypertension (bnp-pl) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356296/ https://www.ncbi.nlm.nih.gov/pubmed/32503164 http://dx.doi.org/10.3390/jcm9061717 |
work_keys_str_mv | AT kwiatkowskajoanna childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT zukmalgorzata childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT migdalanna childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT kusajacek childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT skibaelzbieta childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT zygielokarolina childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT przetockakinga childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT werynskipiotr childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT banaszakpawel childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT rzeznikbieniaszewskaalina childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT surmaczrafal childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT bobkowskiwaldemar childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT wojcickaurbanskabarbara childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT wernerbozena childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT pluzanskajoanna childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT ostrowskakatarzyna childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT waldochanna childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl AT kopecgrzegorz childrenandadolescentswithpulmonaryarterialhypertensionbaselineandfollowupdatafromthepolishregistryofpulmonaryhypertensionbnppl |